お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は上皮成長因子受容体（EGFR）の変異検査市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは上皮成長因子受容体（EGFR）の変異検査の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の上皮成長因子受容体（EGFR）の変異検査市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは上皮成長因子受容体（EGFR）の変異検査のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に上皮成長因子受容体（EGFR）の変異検査市場を分類しています。本研究に含まれる主な企業は：Abbott、Merck、Thermo Fisher Scientific、Illumina、BioMerieux、QIAGEN、Agilent Technologies、Hologic、Novartis、Roche、Genomic Health

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    DNA Sequencing
    Kits

用途別の市場セグメント：
    Cancer Hospitals
    Clinical Research Institutes

本レポートの詳細内容
世界の上皮成長因子受容体（EGFR）の変異検査市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、上皮成長因子受容体（EGFR）の変異検査タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の上皮成長因子受容体（EGFR）の変異検査収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の上皮成長因子受容体（EGFR）の変異検査市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、上皮成長因子受容体（EGFR）の変異検査市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

上皮成長因子受容体（EGFR）の変異検査のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：上皮成長因子受容体（EGFR）の変異検査のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：上皮成長因子受容体（EGFR）の変異検査の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章上皮成長因子受容体（EGFR）の変異検査企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：上皮成長因子受容体（EGFR）の変異検査の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：上皮成長因子受容体（EGFR）の変異検査の主要企業の概要を提供し、製品の説明と仕様、上皮成長因子受容体（EGFR）の変異検査の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Epidermal growth factor receptor (EGFR) is a type of protein, which is located on the surface of human body cells. Any mutation in EGFR gene can lead to various types of cancer. EGFR functions as a biomarker for non-small cell lung cancer (NSCLC) and due to the mutation of EGFR gene a person may suffer from cancer or may have a tumor growth. Tumors with genetically altered EGFR gene are referred to as EGFR-mutated tumors. EGFR mutation is generally observed in NSCLCs, especially in adenocarcinoma tumors. According to the International Association for the Study of Lung Cancer, American Thoracic Society and European Respiratory Society, there are around 50% of surgically resected lung adenocarcinomas in EGFR mutations. These mutations are related to micro papillary predominant subtype and the bronchioloalveolar carcinoma. EGFR biomarker is used in diagnosis of patients with NSCLC. Targeted therapy involving tyrosine kinase inhibitors such as gefitinib and erotinib is used in the treatment of patients with NSCLC. EGFR biomarker detects the presence of specific alterations in EGFR gene, which may lead to the development of tumor.
Market Analysis and Insights: Global EGFR Mutation Test Market
The global EGFR Mutation Test market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Increasing global prevalence of lung cancer is expected to fuel growth of the global EGFR mutation test market over the forecast period. Increasing adoption of biomarker therapy is also expected to boost growth of the market worldwide over the forecast period.
Report Covers:
This report presents an overview of global market for EGFR Mutation Test market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of EGFR Mutation Test, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for EGFR Mutation Test, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the EGFR Mutation Test revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global EGFR Mutation Test market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for EGFR Mutation Test revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott, Merck, Thermo Fisher Scientific, Illumina, BioMerieux, QIAGEN, Agilent Technologies, Hologic and Novartis, etc.

Market Segmentation
By Company
    Abbott
    Merck
    Thermo Fisher Scientific
    Illumina
    BioMerieux
    QIAGEN
    Agilent Technologies
    Hologic
    Novartis
    Roche
    Genomic Health

Segment by Type
    DNA Sequencing
    Kits

Segment by Application
    Cancer Hospitals
    Clinical Research Institutes

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of EGFR Mutation Test in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of EGFR Mutation Test companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, EGFR Mutation Test revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global EGFR Mutation Test Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of DNA Sequencing
    Table 3. Key Players of Kits
    Table 4. Global EGFR Mutation Test Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global EGFR Mutation Test Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global EGFR Mutation Test Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global EGFR Mutation Test Market Share by Region (2019-2024)
    Table 8. Global EGFR Mutation Test Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global EGFR Mutation Test Market Share by Region (2025-2030)
    Table 10. EGFR Mutation Test Market Trends
    Table 11. EGFR Mutation Test Market Drivers
    Table 12. EGFR Mutation Test Market Challenges
    Table 13. EGFR Mutation Test Market Restraints
    Table 14. Global EGFR Mutation Test Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global EGFR Mutation Test Revenue Share by Players (2019-2024)
    Table 16. Global Top EGFR Mutation Test by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in EGFR Mutation Test as of 2023)
    Table 17. Global EGFR Mutation Test Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by EGFR Mutation Test Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of EGFR Mutation Test, Headquarters and Area Served
    Table 20. Global Key Players of EGFR Mutation Test, Product and Application
    Table 21. Global Key Players of EGFR Mutation Test, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global EGFR Mutation Test Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global EGFR Mutation Test Revenue Market Share by Type (2019-2024)
    Table 25. Global EGFR Mutation Test Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global EGFR Mutation Test Revenue Market Share by Type (2025-2030)
    Table 27. Global EGFR Mutation Test Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global EGFR Mutation Test Revenue Share by Application (2019-2024)
    Table 29. Global EGFR Mutation Test Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global EGFR Mutation Test Revenue Share by Application (2025-2030)
    Table 31. North America EGFR Mutation Test Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America EGFR Mutation Test Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America EGFR Mutation Test Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America EGFR Mutation Test Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America EGFR Mutation Test Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America EGFR Mutation Test Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America EGFR Mutation Test Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe EGFR Mutation Test Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe EGFR Mutation Test Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe EGFR Mutation Test Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe EGFR Mutation Test Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe EGFR Mutation Test Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe EGFR Mutation Test Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe EGFR Mutation Test Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China EGFR Mutation Test Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China EGFR Mutation Test Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China EGFR Mutation Test Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China EGFR Mutation Test Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia EGFR Mutation Test Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia EGFR Mutation Test Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia EGFR Mutation Test Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia EGFR Mutation Test Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia EGFR Mutation Test Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia EGFR Mutation Test Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia EGFR Mutation Test Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America EGFR Mutation Test Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America EGFR Mutation Test Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America EGFR Mutation Test Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America EGFR Mutation Test Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America EGFR Mutation Test Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America EGFR Mutation Test Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America EGFR Mutation Test Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Abbott Company Details
    Table 64. Abbott Business Overview
    Table 65. Abbott EGFR Mutation Test Product
    Table 66. Abbott Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)
    Table 67. Abbott Recent Developments
    Table 68. Merck Company Details
    Table 69. Merck Business Overview
    Table 70. Merck EGFR Mutation Test Product
    Table 71. Merck Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)
    Table 72. Merck Recent Developments
    Table 73. Thermo Fisher Scientific Company Details
    Table 74. Thermo Fisher Scientific Business Overview
    Table 75. Thermo Fisher Scientific EGFR Mutation Test Product
    Table 76. Thermo Fisher Scientific Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)
    Table 77. Thermo Fisher Scientific Recent Developments
    Table 78. Illumina Company Details
    Table 79. Illumina Business Overview
    Table 80. Illumina EGFR Mutation Test Product
    Table 81. Illumina Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)
    Table 82. Illumina Recent Developments
    Table 83. BioMerieux Company Details
    Table 84. BioMerieux Business Overview
    Table 85. BioMerieux EGFR Mutation Test Product
    Table 86. BioMerieux Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)
    Table 87. BioMerieux Recent Developments
    Table 88. QIAGEN Company Details
    Table 89. QIAGEN Business Overview
    Table 90. QIAGEN EGFR Mutation Test Product
    Table 91. QIAGEN Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)
    Table 92. QIAGEN Recent Developments
    Table 93. Agilent Technologies Company Details
    Table 94. Agilent Technologies Business Overview
    Table 95. Agilent Technologies EGFR Mutation Test Product
    Table 96. Agilent Technologies Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)
    Table 97. Agilent Technologies Recent Developments
    Table 98. Hologic Company Details
    Table 99. Hologic Business Overview
    Table 100. Hologic EGFR Mutation Test Product
    Table 101. Hologic Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)
    Table 102. Hologic Recent Developments
    Table 103. Novartis Company Details
    Table 104. Novartis Business Overview
    Table 105. Novartis EGFR Mutation Test Product
    Table 106. Novartis Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)
    Table 107. Novartis Recent Developments
    Table 108. Roche Company Details
    Table 109. Roche Business Overview
    Table 110. Roche EGFR Mutation Test Product
    Table 111. Roche Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)
    Table 112. Roche Recent Developments
    Table 113. Genomic Health Company Details
    Table 114. Genomic Health Business Overview
    Table 115. Genomic Health EGFR Mutation Test Product
    Table 116. Genomic Health Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)
    Table 117. Genomic Health Recent Developments
    Table 118. Research Programs/Design for This Report
    Table 119. Key Data Information from Secondary Sources
    Table 120. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global EGFR Mutation Test Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global EGFR Mutation Test Market Share by Type: 2023 VS 2030
    Figure 3. DNA Sequencing Features
    Figure 4. Kits Features
    Figure 5. Global EGFR Mutation Test Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global EGFR Mutation Test Market Share by Application: 2023 VS 2030
    Figure 7. Cancer Hospitals Case Studies
    Figure 8. Clinical Research Institutes Case Studies
    Figure 9. EGFR Mutation Test Report Years Considered
    Figure 10. Global EGFR Mutation Test Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 11. Global EGFR Mutation Test Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global EGFR Mutation Test Market Share by Region: 2023 VS 2030
    Figure 13. Global EGFR Mutation Test Market Share by Players in 2023
    Figure 14. Global Top EGFR Mutation Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in EGFR Mutation Test as of 2023)
    Figure 15. The Top 10 and 5 Players Market Share by EGFR Mutation Test Revenue in 2023
    Figure 16. North America EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 17. North America EGFR Mutation Test Market Share by Type (2019-2030)
    Figure 18. North America EGFR Mutation Test Market Share by Application (2019-2030)
    Figure 19. North America EGFR Mutation Test Market Share by Country (2019-2030)
    Figure 20. United States EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Canada EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe EGFR Mutation Test Market Size YoY (2019-2030) & (US$ Million)
    Figure 23. Europe EGFR Mutation Test Market Share by Type (2019-2030)
    Figure 24. Europe EGFR Mutation Test Market Share by Application (2019-2030)
    Figure 25. Europe EGFR Mutation Test Market Share by Country (2019-2030)
    Figure 26. Germany EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. France EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. U.K. EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Italy EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Russia EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Nordic Countries EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. China EGFR Mutation Test Market Size YoY (2019-2030) & (US$ Million)
    Figure 33. China EGFR Mutation Test Market Share by Type (2019-2030)
    Figure 34. China EGFR Mutation Test Market Share by Application (2019-2030)
    Figure 35. Asia EGFR Mutation Test Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. Asia EGFR Mutation Test Market Share by Type (2019-2030)
    Figure 37. Asia EGFR Mutation Test Market Share by Application (2019-2030)
    Figure 38. Asia EGFR Mutation Test Market Share by Region (2019-2030)
    Figure 39. Japan EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. South Korea EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. China Taiwan EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Southeast Asia EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. India EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Australia EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East, Africa, and Latin America EGFR Mutation Test Market Size YoY (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America EGFR Mutation Test Market Share by Type (2019-2030)
    Figure 47. Middle East, Africa, and Latin America EGFR Mutation Test Market Share by Application (2019-2030)
    Figure 48. Middle East, Africa, and Latin America EGFR Mutation Test Market Share by Country (2019-2030)
    Figure 49. Brazil EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Mexico EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Turkey EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Israel EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. GCC Countries EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Abbott Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)
    Figure 56. Merck Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)
    Figure 57. Thermo Fisher Scientific Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)
    Figure 58. Illumina Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)
    Figure 59. BioMerieux Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)
    Figure 60. QIAGEN Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)
    Figure 61. Agilent Technologies Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)
    Figure 62. Hologic Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)
    Figure 63. Novartis Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)
    Figure 64. Roche Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)
    Figure 65. Genomic Health Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed